The interaction of PKN3 with RhoC promotes malignant growth. - Wikidata - awgldk - TriplyDB

The interaction of PKN3 with RhoC promotes malignant growth.

The interaction of PKN3 with RhoC promotes malignant growth.

http://www.wikidata.org/entity/Q39417786

about

Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging Delivery of gene silencing agents for breast cancer therapy A RhoC biosensor reveals differences in the activation kinetics of RhoA and RhoC in migrating cells RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting Toward understanding RhoGTPase specificity: structure, function and local activation.Disruption of the protein kinase N gene of drosophila melanogaster results in the recessive delorean allele (pkndln) with a negative impact on wing morphogenesis Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.PKN3 is the major regulator of angiogenesis and tumor metastasis in mice Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons.Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Therapeutic effects of protein kinase N3 small interfering RNA and doxorubicin combination therapy on liver and lung metastases.Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.Protein kinase N3 deficiency impedes PI3-kinase pathway-driven leukemogenesis without affecting normal hematopoiesis.

P2860

Q26778234-D2AEF9EC-EFD1-4246-96E7-BFC3C9DA9193 Q27008706-80DB628B-F42E-4454-825F-801D272EF6EC Q27302353-204E5903-DE44-44AC-96EB-41B8C90081EB Q30301104-3C965322-BCD4-425F-8FC1-E7D74E0EACDA Q30456053-380989D8-A437-4049-9DF7-64D494D5BFDB Q30667628-AE84A4E7-2D37-473F-95D0-3192FBAF14E0 Q33761690-F642196F-6D66-4678-A9A2-C65FD06A294F Q36213543-D9678068-AA62-4F72-BFBF-FCA24C14423E Q36442867-45715E32-B865-419B-975D-8EB7880E6526 Q38213708-21332184-1BA6-455D-B74E-52DC337B2F42 Q38841874-ABD79353-C445-40B9-AF12-F40379320491 Q38928703-7E3F46AC-3D3C-4857-BFB0-BC9A5DA6F1F5 Q39227810-CC86C1BE-27D3-42D3-A1C7-43955432686F Q47127282-4D08371F-6EB2-4516-A8A0-E9FB0AC87DD8 Q53556916-38156683-BFDA-4BF1-87AF-C354EEB3EC27 Q54321176-3E9726F9-0A12-492C-9481-57A1735CBC5F

P2860

The interaction of PKN3 with RhoC promotes malignant growth.

http://www.wikidata.org/entity/Q39417786

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The interaction of PKN3 with RhoC promotes malignant growth.

@en

The interaction of PKN3 with RhoC promotes malignant growth.

@nl

type

label

The interaction of PKN3 with RhoC promotes malignant growth.

@en

The interaction of PKN3 with RhoC promotes malignant growth.

@nl

prefLabel

The interaction of PKN3 with RhoC promotes malignant growth.

@en

The interaction of PKN3 with RhoC promotes malignant growth.

@nl

P1433

Q39417786-EFA1EF49-77A3-495E-99ED-0FB49FDAB82B

P1476

Q39417786-ADEC9A6B-814D-477C-9F84-5792ACD83584

P2093

Q39417786-163ED9A3-56FF-4A89-9CB2-02C0548FB8A2

Q39417786-23EF56AB-E231-47BF-8EE0-194BC5141C58

Q39417786-59A88139-000F-4ABE-9617-68EBF9CFA71C

Q39417786-5F20E905-F3C7-47FA-AE50-01EC5759B867

Q39417786-70AEFA16-D37A-4EA4-BEC4-5E58A1F1A0FB

Q39417786-958DAAAD-FE50-41B9-B799-4AC8B0C72C1B

Q39417786-B1387AB5-0A94-43D4-9BC8-B609FE027454

Q39417786-E81D9068-5923-49BE-B0D5-9B07AD7464A4

Q39417786-FDD4F23D-655A-4F29-924A-A31AA58E58C0

P2860

Q39417786-0406070F-BBFD-4EE1-9217-9107FD9866E9

Q39417786-0B2049A4-863A-44B1-8D8D-B37DAB52938A

Q39417786-1216B439-58D2-40DA-9BCB-0D2CFAEBC215

Q39417786-1C32A4EF-5867-4878-AD0E-2A92A5C3B920

Q39417786-26D91CE4-7B0A-4DC6-8C42-3FFF9990615E

Q39417786-2819195D-B35F-4ACA-9886-CAB7BD84AC7E

Q39417786-286A85DA-3CDD-402A-B680-2A02F8A2D25F

Q39417786-2ADA47B3-B567-45BA-A647-7BC33E35A75E

Q39417786-31CE493D-F45A-4979-8359-58BFEA9B188A

Q39417786-3912EB8E-A33D-4D3F-9A85-9A74C42161B4

P304

Q39417786-EB4556F2-85AF-421B-AF67-11F93796022A

P31

Q39417786-024AF2D1-E07E-45C1-86B7-389ABB2CE1EB

P356

Q39417786-6AFC2931-6893-46F1-967D-05DF025F462E

P433

Q39417786-DB7F85B8-879C-4650-825A-BCA5D042E913

P478

Q39417786-46BD8E68-6557-47A7-AEFC-3BD7F59C7555

P577

Q39417786-6A9E4786-1C1C-4F1F-9FFD-B08F3E945572

P5875

Q39417786-1AB4A4D4-15C9-44B6-803E-FBE29C2A2D84

P698

Q39417786-E7A5BB71-AFC4-4691-BB80-EDAB9E6E236F

P932

Q39417786-6EA212A8-AFCB-4BBC-88DB-E648AE5F664D

P356

J.MOLONC.2011.12.001

P1433

Molecular Oncology

P1476

The interaction of PKN3 with RhoC promotes malignant growth.

@en

P2093

Anke Klippel

http://www.w3.org/2001/XMLSchema#string

Edward Rosfjord

http://www.w3.org/2001/XMLSchema#string

Erik Upeslacis

http://www.w3.org/2001/XMLSchema#string

Fiona Mack

http://www.w3.org/2001/XMLSchema#string

Keziban Unsal-Kacmaz

http://www.w3.org/2001/XMLSchema#string

Mary Grillo

http://www.w3.org/2001/XMLSchema#string

Richard Hernandez

http://www.w3.org/2001/XMLSchema#string

Shoba Ragunathan

http://www.w3.org/2001/XMLSchema#string

Stephen Dann

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of PKNbeta, a novel isoform of protein kinase PKN: expression and arachidonic acid dependency are different from those of PKNalpha

Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton

Coupling of human circadian and cell cycles by the timeless protein.

A novel protein kinase with leucine zipper-like sequences: its catalytic domain is highly homologous to that of protein kinase C

A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization

The epithelial-mesenchymal transition generates cells with properties of stem cells

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability

P304

284-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2011.12.001

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51982334

http://www.w3.org/2001/XMLSchema#string

P698

22217540

http://www.w3.org/2001/XMLSchema#string

P932

5528337

http://www.w3.org/2001/XMLSchema#string